Ascopiave S.p.A.
ASCOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 1.96 | -1.05 | -1.05 |
| FCF Yield | 2.87% | -8.62% | 1.19% | -0.25% |
| EV / EBITDA | 9.60 | 13.27 | 15.30 | 14.20 |
| Quality | ||||
| ROIC | 2.84% | 2.96% | 1.80% | 2.12% |
| Gross Margin | 95.10% | 94.34% | 93.54% | 77.45% |
| Cash Conversion Ratio | 2.77 | 0.17 | 2.81 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.79% | 10.25% | -0.05% | 2.60% |
| Free Cash Flow Growth | 124.70% | -801.00% | 610.50% | -0.04% |
| Safety | ||||
| Net Debt / EBITDA | 3.44 | 3.92 | 4.35 | 3.92 |
| Interest Coverage | 3.35 | 4.14 | 6.22 | 21.48 |
| Efficiency | ||||
| Inventory Turnover | 1.43 | 1.24 | 1.44 | 3.72 |
| Cash Conversion Cycle | -1,944.76 | -2,242.62 | -5,657.78 | -314.62 |